Lumos Pharma (LUMO)
(Delayed Data from NSDQ)
$3.76 USD
-0.17 (-4.33%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $3.77 +0.01 (0.27%) 5:18 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.50 | 0.00% |
Earnings Summary
For their last quarter, Lumos Pharma (LUMO) reported earnings of -$0.93 per share, beating the Zacks Consensus Estimate of $-1.26 per share. This reflects a positive earnings surprise of 26.19%. Look out for LUMO's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.50 per share, reflecting a year-over-year increase of 51.92%.
Earnings History
Price & Consensus
Zacks News for LUMO
Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
LUMO: What are Zacks experts saying now?
Zacks Private Portfolio Services